Cargando…

Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim–Chester Disease

Pericarditis is an inflammatory heart disease, which may be idiopathic or secondary to autoimmune or auto-inflammatory diseases and often leads to severe or life-threatening complications. Colchicine and non-steroidal anti-inflammatory drugs represent the mainstay of treatment, whereas use of cortic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomelleri, Alessandro, Cavalli, Giulio, De Luca, Giacomo, Campochiaro, Corrado, D’Aliberti, Teresa, Tresoldi, Moreno, Dagna, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992291/ https://www.ncbi.nlm.nih.gov/pubmed/29910817 http://dx.doi.org/10.3389/fimmu.2018.01233

Ejemplares similares

Cardiovascular involvement in Erdheim–Chester diseases is associated with myocardial fibrosis and atrial dysfunction
por: Palmisano, Anna, et al.
Publicado: (2023)

Multimodal Chorioretinal Imaging in Erdheim-Chester Disease
por: Sacconi, Riccardo, et al.
Publicado: (2020)

Myocarditis: An Interleukin-1-Mediated Disease?
por: De Luca, Giacomo, et al.
Publicado: (2018)

PB2199: GEOGRAPHIC CLUSTERING OF ERDHEIM-CHESTER DISEASE IN ITALY AND FRANCE
por: Peyronel, Francesco, et al.
Publicado: (2023)

Cardiac electrical instability in Erdheim-Chester disease: a case report
por: Urbani, Andrea, et al.
Publicado: (2022)

Oncogene-Induced Senescence as a New Mechanism of Disease: The Paradigm of Erdheim–Chester Disease
por: Cavalli, Giulio, et al.
Publicado: (2014)

Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement
por: De Luca, Giacomo, et al.
Publicado: (2021)

The conundrum of interleukin-6 blockade in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic
por: Cavalli, Giulio, et al.
Publicado: (2020)

Erdheim–Chester Disease With Multiorgan Involvement, Following Polycythemia Vera: A Case Report
por: Iurlo, Alessandra, et al.
Publicado: (2016)

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
por: De Luca, Giacomo, et al.
Publicado: (2020)

Erdheim-Chester Disease
por: Yamamoto, Shinya, et al.
Publicado: (2019)

Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
por: Cavalli, Giulio, et al.
Publicado: (2019)

Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure
por: Cavalli, Giulio, et al.
Publicado: (2017)

Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2021)

Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease
por: Cavalli, Giulio, et al.
Publicado: (2019)

3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target
por: Villa, Antonello, et al.
Publicado: (2019)

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
por: Cavalli, Giulio, et al.
Publicado: (2021)

Rationale and efficacy of interleukin-1 targeting in pediatric Erdheim- Chester disease
por: Tran, TA, et al.
Publicado: (2011)

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
por: Cavalli, Giulio, et al.
Publicado: (2020)

Unusual manifestation of Erdheim-Chester disease
por: Pan, Antony, et al.
Publicado: (2011)

Neurological Involvement in Erdheim-Chester Disease
por: Álvarez-Álvarez, Miriam, et al.
Publicado: (2016)

Kidney Transplantation for Erdheim-Chester Disease
por: Yoo, Jongwon, et al.
Publicado: (2020)

Neurological manifestations of Erdheim–Chester Disease
por: Boyd, Louisa C., et al.
Publicado: (2020)

Clinical Images: Erdheim‐Chester disease
por: Mehta, Rohan, et al.
Publicado: (2021)

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
por: Della-Torre, Emanuel, et al.
Publicado: (2020)

One year later: The case of tocilizumab in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2022)

PB2208: CLUSTER ANALYSIS UNVEILS THE CLINICAL SPECTRUM OF ERDHEIM-CHESTER DISEASE
por: Tesi, Michelangelo, et al.
Publicado: (2023)

Erdheim-Chester disease: a case report.
por: Park, Y. K., et al.
Publicado: (1999)

Erdheim-Chester Disease: A Case Report
por: Alexiou, Jean, et al.
Publicado: (2015)

Erdheim Chester Disease treated successfully with cladribine
por: Azadeh, Natalya, et al.
Publicado: (2016)

Erdheim — Chester disease: Clinical pearls for the anesthesiologist
por: Hariharan, Uma, et al.
Publicado: (2014)

Isolated pulmonary involvement in Erdheim–Chester disease
por: Josan, Enambir Singh, et al.
Publicado: (2017)

Erdheim-Chester disease with isolated neurological involvement
por: Loureiro, Bruna Melo Coelho, et al.
Publicado: (2018)

A possible case of Erdheim–Chester Disease
por: Martiniuc, Georgeta, et al.
Publicado: (2018)

Erdheim-Chester Disease: The Importance of Information Integration
por: Nikonova, Anna, et al.
Publicado: (2017)

Multisystem Radiologic Manifestations of Erdheim-Chester Disease
por: Lodhi, Umairullah, et al.
Publicado: (2016)

A Diagnostic Challenge: Erdheim Chester Disorder
por: Razi, Mairah, et al.
Publicado: (2019)

Prevalence of Hypothyroidism in Patients With Erdheim-Chester Disease
por: Shekhar, Skand, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bklqlfjpjnj4p02i1p00p6p7ac